Sharps Technology, Inc.
Soren Christiansen worked as the Chairman and CEO of Sharps Technology, Inc. starting from April 2018. At Sharps Technology, they led the development and implementation of the Sharps Provensa smart safety syringes, which aimed to eliminate accidental needlestick injuries and inefficiency in medication usage within the global healthcare industry. Prior to this, Soren Christiansen also held the position of President at Merck from February 1988 to December 2017.
Soren Christiansen attended the University of Copenhagen from 1976 to 1985, where they pursued a degree in Medicine. Soren successfully completed their studies and obtained a Doctor of Arts degree.
This person is not in any teams
This person is not in any offices
Sharps Technology, Inc.
Sharps Technology is an innovative medical device company introducing a new patented best in class single use safety syringe. Their “game changing technology” programs are designed to eliminate an estimated 2 million accidental infectious needle sticks each year. PROMESIA™ is poised to help change the risk of exposure to the 14 billion injectionsgiven each year.